These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38308405)

  • 1. An estimate of the need for continuous glucose monitoring in type 2 diabetes with intensive insulin treatment in secondary healthcare.
    Trolle C; Christensen M; Hansen KW
    Diabet Med; 2024 May; 41(5):e15298. PubMed ID: 38308405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SELF BLOOD GLUCOSE MONITORING UNDERESTIMATES HYPERGLYCEMIA AND HYPOGLYCEMIA AS COMPARED TO CONTINUOUS GLUCOSE MONITORING IN TYPE 1 AND TYPE 2 DIABETES.
    Mangrola D; Cox C; Furman AS; Krishnan S; Karakas SE
    Endocr Pract; 2018 Jan; 24(1):47-52. PubMed ID: 29144814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Flash Glucose Monitoring and Glycemic Control in Patients with Type 2 Diabetes Mellitus Not Treated with an Intensive Insulin Regimen: 1-Year Real-Life Retrospective Cohort Study.
    Al Hayek AA; Al Dawish MA
    Adv Ther; 2023 Jun; 40(6):2855-2868. PubMed ID: 37133646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world outcomes of continuous glucose monitoring in adults with diabetes mellitus attending an Irish tertiary hospital.
    Courtney A; Smith D; Forde H
    Ir J Med Sci; 2023 Dec; 192(6):2763-2768. PubMed ID: 36940009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France.
    Alshannaq H; Pollock RF; Joubert M; Ahmed W; Norman GJ; Lynch PM; Roze S
    J Comp Eff Res; 2024 Mar; 13(3):e230174. PubMed ID: 38294332
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
    Heller S; Koenen C; Bode B
    Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life 24-week changes in glycemic parameters among European users of flash glucose monitoring with type 1 and 2 diabetes and different levels of glycemic control.
    Lameijer A; Bakker JJ; Kao K; Xu Y; Gans ROB; Bilo HJG; Dunn TC; van Dijk PR
    Diabetes Res Clin Pract; 2023 Jul; 201():110735. PubMed ID: 37276981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study.
    Képénékian L; Smagala A; Meyer L; Imhoff O; Alenabi F; Serb L; Fleury D; Dorey F; Krummel T; Le Floch JP; Chantrel F; Kessler L
    Clin Nephrol; 2014 Oct; 82(4):240-6. PubMed ID: 25161114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of remote monitoring Technology in Optimizing Traditional Self-Monitoring of blood glucose in adults with T2DM in primary care.
    Montero AR; Toro-Tobon D; Gann K; Nassar CM; Youssef GA; Magee MF
    BMC Endocr Disord; 2021 Nov; 21(1):222. PubMed ID: 34758807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
    Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
    Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between metabolic control and self-monitoring of blood glucose in insulin-treated patients with diabetes mellitus.
    Soto González A; Quintela Fernández N; Pumar López A; Darias Garzón R; Rivas Fernández M; Barberá Comes G
    Endocrinol Nutr; 2015 May; 62(5):233-9. PubMed ID: 25814324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-Series Analysis of Continuous Glucose Monitoring Data to Predict Treatment Efficacy in Patients with T2DM.
    Li L; Sun J; Ruan L; Song Q
    J Clin Endocrinol Metab; 2021 Jul; 106(8):2187-2197. PubMed ID: 34010405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intermittently scanned continuous glucose monitoring on quality of life and glycaemic control in persons with type 1 diabetes: A 12-month follow-up study in real life.
    Duarte DB; Fonseca L; Santos T; Silva VB; Puga FM; Saraiva M; Silva IL; Teixeira S; Vilaverde J; Cardoso MH
    Diabetes Metab Syndr; 2022 Jun; 16(6):102509. PubMed ID: 35598543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With Multiple Daily Insulin Injections: An Analysis Based on the GOLD Randomized Trial (GOLD 8).
    Nyström T; Schwarz E; Dahlqvist S; Wijkman M; Ekelund M; Holmer H; Bolinder J; Hellman J; Imberg H; Hirsch IB; Lind M
    J Diabetes Sci Technol; 2024 Jan; 18(1):89-98. PubMed ID: 35677967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.